{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:53:12Z","timestamp":1789609992709,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms8650","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T12:43:10Z","timestamp":1436272990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pirt reduces bladder overactivity by inhibiting purinergic receptor P2X3"],"prefix":"10.1038","volume":"6","author":[{"given":"Xiao-Fei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Hua","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Xiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Zhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"BFncomms8650_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrurol.2012.217","volume":"9","author":"J Neuhaus","year":"2012","unstructured":"Neuhaus, J. & Schwalenberg, T. Intravesical treatments of bladder pain syndrome\/interstitial cystitis. Nat. Rev. Urol. 9, 707\u2013720 (2012).","journal-title":"Nat. Rev. Urol."},{"key":"BFncomms8650_CR2","first-page":"934","volume":"5","author":"MS Rahnama\u2019I","year":"2013","unstructured":"Rahnama\u2019I, M. S., Van Koeveringe, G. A. & Van Kerrebroeck, P. E. Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introduction. Nephrourol. Mon. 5, 934\u2013945 (2013).","journal-title":"Nephrourol. Mon."},{"key":"BFncomms8650_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5213\/inj.2011.15.3.143","volume":"15","author":"ES Yoo","year":"2011","unstructured":"Yoo, E. S., Kim, B. S., Kim, D. Y., Oh, S. J. & Kim, J. C. The impact of overactive bladder on health-related quality of life, sexual life and psychological health in Korea. Int. Neurourol. J. 15, 143\u2013151 (2011).","journal-title":"Int. Neurourol. J."},{"key":"BFncomms8650_CR4","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.5489\/cuaj.11182","volume":"5","author":"KE Andersson","year":"2011","unstructured":"Andersson, K. E. Drugs and future candidates. Can. Urol. Assoc. J. 5, S131\u2013S133 (2011).","journal-title":"Can. Urol. Assoc. J."},{"key":"BFncomms8650_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1464-410X.2007.06698.x","volume":"99","author":"L Cardozo","year":"2007","unstructured":"Cardozo, L. The overactive bladder syndrome: treating patients on an individual basis. BJU Int. 99, 1\u20137 (2007).","journal-title":"BJU Int."},{"key":"BFncomms8650_CR6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/bju.12266","volume":"112","author":"VM Collins","year":"2013","unstructured":"Collins, V. M. et al. OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium. BJU Int. 112, 1018\u20131026 (2013).","journal-title":"BJU Int."},{"key":"BFncomms8650_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/physrev.00030.2012","volume":"93","author":"L Birder","year":"2013","unstructured":"Birder, L. & Andersson, K. E. Urothelial signaling. Physiol. Rev. 93, 653\u2013680 (2013).","journal-title":"Physiol. Rev."},{"key":"BFncomms8650_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2012.11.053","volume":"700","author":"SH Kang","year":"2013","unstructured":"Kang, S. H., Chess-Williams, R., Anoopkumar-Dukie, S. & McDermott, C. Induction of inflammatory cytokines and alteration of urothelial ATP, acetylcholine and prostaglandin E2 release by doxorubicin. Eur. J. Pharmacol. 700, 102\u2013109 (2013).","journal-title":"Eur. J. Pharmacol."},{"key":"BFncomms8650_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.coph.2011.10.008","volume":"12","author":"G Burnstock","year":"2012","unstructured":"Burnstock, G. Targeting the visceral purinergic system for pain control. Curr. Opin. Pharmacol. 12, 80\u201386 (2012).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFncomms8650_CR10","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1523\/JNEUROSCI.21-15-05670.2001","volume":"21","author":"M Vlaskovska","year":"2001","unstructured":"Vlaskovska, M. et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J. Neurosci. 21, 5670\u20135677 (2001).","journal-title":"J. Neurosci."},{"key":"BFncomms8650_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/35039519","volume":"407","author":"DA Cockayne","year":"2000","unstructured":"Cockayne, D. A. et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407, 1011\u20131015 (2000).","journal-title":"Nature"},{"key":"BFncomms8650_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cell.2008.02.053","volume":"133","author":"AY Kim","year":"2008","unstructured":"Kim, A. Y. et al. Pirt, a phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1. Cell 133, 475\u2013485 (2008).","journal-title":"Cell"},{"key":"BFncomms8650_CR13","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/ncomms3179","volume":"4","author":"Z Tang","year":"2013","unstructured":"Tang, Z. et al. Pirt functions as an endogenous regulator of TRPM8. Nat. Commun. 4, 2179 (2013).","journal-title":"Nat. Commun."},{"key":"BFncomms8650_CR14","doi-asserted-by":"publisher","first-page":"F1084","DOI":"10.1152\/ajprenal.00118.2004","volume":"287","author":"LA Birder","year":"2004","unstructured":"Birder, L. A. et al. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am. J. Physiol. Renal. Physiol. 287, F1084\u2013F1091 (2004).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"BFncomms8650_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fncel.2013.00245","volume":"7","author":"R Giniatullin","year":"2013","unstructured":"Giniatullin, R. & Nistri, A. Desensitization properties of P2X3 receptors shaping pain signaling. Front. Cell Neurosci. 7, 245 (2013).","journal-title":"Front. Cell Neurosci."},{"key":"BFncomms8650_CR16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","volume":"285","author":"SR Schwarze","year":"1999","unstructured":"Schwarze, S. R., Ho, A., Vocero-Akbani, A. & Dowdy, S. F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569\u20131572 (1999).","journal-title":"Science"},{"key":"BFncomms8650_CR17","first-page":"1","volume":"6","author":"J Jayarajan","year":"2013","unstructured":"Jayarajan, J. & Radomski, S. B. Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life. Res. Rep. Urol. 6, 1\u201316 (2013).","journal-title":"Res. Rep. Urol."},{"key":"BFncomms8650_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2353\/ajpath.2008.070529","volume":"172","author":"M Martinez-Ferrer","year":"2008","unstructured":"Martinez-Ferrer, M. et al. Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation. Am. J. Pathol. 172, 59\u201367 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFncomms8650_CR19","doi-asserted-by":"publisher","first-page":"19084","DOI":"10.1073\/pnas.1005333107","volume":"107","author":"W Everaerts","year":"2010","unstructured":"Everaerts, W. et al. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc. Natl Acad. Sci. USA 107, 19084\u201319089 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms8650_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2013.03.008","volume":"707","author":"C Aug\u00e9","year":"2013","unstructured":"Aug\u00e9, C. et al. Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder. Eur. J. Pharmacol. 707, 32\u201340 (2013).","journal-title":"Eur. J. Pharmacol."},{"key":"BFncomms8650_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/nau.22202","volume":"31","author":"P Hanno","year":"2012","unstructured":"Hanno, P. et al. Chronic pelvic pain syndrome\/bladder pain syndrome: taking stock, looking ahead: ICI-RS 2011. Neurourol. Urodyn. 31, 375\u2013383 (2012).","journal-title":"Neurourol. Urodyn."},{"key":"BFncomms8650_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1442-2042.2012.03210.x","volume":"20","author":"LA Birder","year":"2013","unstructured":"Birder, L. A. Nervous network for lower urinary tract function. Int. J. Urol. 20, 4\u201312 (2013).","journal-title":"Int. J. Urol."},{"key":"BFncomms8650_CR23","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1464-410X.2004.04858.x","volume":"93","author":"HV Tempest","year":"2004","unstructured":"Tempest, H. V. et al. P2X2 and P2X3 receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int. 93, 1344\u20131348 (2004).","journal-title":"BJU Int."},{"key":"BFncomms8650_CR24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature08198","volume":"460","author":"T Kawate","year":"2009","unstructured":"Kawate, T., Michel, J. C., Birdsong, W. T. & Gouaux, E. Crystal structure of the ATP-gated P2X4 ion channel in the closed state. Nature 460, 592\u2013598 (2009).","journal-title":"Nature"},{"key":"BFncomms8650_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11010","volume":"485","author":"M Hattori","year":"2012","unstructured":"Hattori, M. & Gouaux, E. Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485, 207\u2013212 (2012).","journal-title":"Nature"},{"key":"BFncomms8650_CR26","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/01.ju.0000134880.55119.cf","volume":"172","author":"RJ Stein","year":"2004","unstructured":"Stein, R. J. et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J. Urol. 172, 1175\u20131178 (2004).","journal-title":"J. Urol."},{"key":"BFncomms8650_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrurol.2011.142","volume":"8","author":"R Skryma","year":"2011","unstructured":"Skryma, R., Prevarskaya, N., Gkika, D. & Shuba, Y. From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat. Rev. Urol. 8, 617\u2013630 (2011).","journal-title":"Nat. Rev. Urol."},{"key":"BFncomms8650_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11934-012-0264-y","volume":"13","author":"CS Elliott","year":"2012","unstructured":"Elliott, C. S. & Payne, C. K. Interstitial cystitis and the overlap with overactive bladder. Curr. Urol. Rep. 13, 319\u2013326 (2012).","journal-title":"Curr. Urol. Rep."},{"key":"BFncomms8650_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11302-013-9395-y","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock, G. Purinergic signalling in the urinary tract in health and disease. Purinergic Signal. 10, 103\u2013155 (2014).","journal-title":"Purinergic Signal."},{"key":"BFncomms8650_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1152\/jn.00211.2007","volume":"99","author":"K Dang","year":"2008","unstructured":"Dang, K., Lamb, K., Cohen, M., Bielefeldt, K. & Gebhart, G. F. Cyclophosphamide-induced bladder inflammation sensitizes and enhances P2X receptor function in rat bladder sensory neurons. J. Neurophysiol. 99, 49\u201359 (2008).","journal-title":"J. Neurophysiol."},{"key":"BFncomms8650_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.juro.2013.11.026","volume":"191","author":"Y Funahashi","year":"2014","unstructured":"Funahashi, Y. et al. Intravesical application of rebamipide suppresses bladder inflammation in a rat cystitis model. J. Urol. 191, 1147\u20131152 (2014).","journal-title":"J. Urol."},{"key":"BFncomms8650_CR32","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/0006-2952(79)90222-3","volume":"28","author":"PJ Cox","year":"1979","unstructured":"Cox, P. J. Cyclophosphamide cystitis\u2014identification of acrolein as the causative agent. Biochem. Pharmacol. 28, 2045\u20132049 (1979).","journal-title":"Biochem. Pharmacol."},{"key":"BFncomms8650_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/nau.21078","volume":"30","author":"DE Bjorling","year":"2011","unstructured":"Bjorling, D. E., Wang, Z. Y. & Bushman, W. Models of inflammation of the lower urinary tract. Neurourol. Urodyn. 30, 673\u2013682 (2011).","journal-title":"Neurourol. Urodyn."},{"key":"BFncomms8650_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11302-011-9249-4","volume":"8","author":"X Song","year":"2012","unstructured":"Song, X. et al. Expression of P2X(2) and P2X(3) receptors in the rat carotid sinus, aortic arch, vena cava, and heart, as well as petrosal and nodose ganglia. Purinergic Signal. 8, 15\u201322 (2012).","journal-title":"Purinergic Signal."},{"key":"BFncomms8650_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cbi.2013.03.008","volume":"203","author":"FC Meotti","year":"2013","unstructured":"Meotti, F. C., Forner, S., Lima-Garcia, J. F., Viana, A. F. & Calixto, J. B. Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis. Chem. Biol. Interact. 203, 440\u2013447 (2013).","journal-title":"Chem. Biol. Interact."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms8650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms8650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms8650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T21:57:50Z","timestamp":1717970270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms8650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,24]]}},"alternative-id":["BFncomms8650"],"URL":"https:\/\/doi.org\/10.1038\/ncomms8650","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]},"assertion":[{"value":"5 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7650"}}